Psychiatry Research
Volume 170, Issue 2 , Pages 204-207 , 30 December 2009

An association study of the serotonin transporter and receptor genes with the suicidal ideation of major depression in a Chinese Han population

  • Shan Wang

      Affiliations

    • Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan, 030001, China
    • ,
  • Kerang Zhang

      Affiliations

    • Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan, 030001, China
    • Corresponding Author InformationCorresponding authors. K. Zhang is to be contacted at Tel.: +86 351 4639869; fax: +86 351 4639956. Xu, Tel.: +86 10 65296432; fax: +86 10 65263392.
    • ,
  • Yong Xu

      Affiliations

    • Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan, 030001, China
    • ,
  • Ning Sun

      Affiliations

    • Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan, 030001, China
    • ,
  • Yan Shen

      Affiliations

    • Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, 100005, China
    • ,
  • Qi Xu

      Affiliations

    • Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, 100005, China
    • Corresponding Author InformationCorresponding authors. K. Zhang is to be contacted at Tel.: +86 351 4639869; fax: +86 351 4639956. Xu, Tel.: +86 10 65296432; fax: +86 10 65263392.

Received 25 April 2008 ,Revised 1 December 2008 ,Accepted 22 December 2008.

References 

  1. Arranz B, Eriksson A, Mellerup P, Plenge J, Marcusson J. Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biological Psychiatry. 1994;35:457–463
  2. Bondy B, Erfurth A, de Jonge S, Kruger M, Meyer H. Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide. Molecular Psychiatry. 2000;5:193–195
  3. Cervilla JA, Rivera M, Molina E, Torres-Gonzalez F, Bellon JA, Moreno B, et al. The 5-HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: the PREDICT-gene study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2006;141:912–917
  4. Courtet P, Buresi C, Abbar M, Baud P, Boulenger JP, Castelnau D, et al. No association between non-violent suicidal behavior and the serotonin transporter promoter polymorphism. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2003;116:72–76
  5. Du L, Bakish D, Lapierre YD, Ravindran AV, Hrdina PD. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. American Journal of Medical Genetics. 2000;96:56–60
  6. Duan J, Sanders AR, Molen JE, Martinolich L, Mowry BJ, Levinson DF, et al. Polymorphisms in the 5′-untranslated region of the human serotonin receptor 1B (HTR1B) gene affect gene expression. Molecular Psychiatry. 2003;8:901–910
  7. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genetic Epidemiology. 2003;25:115–121
  8. Hranilovic D, Stefulj J, Furac I, Kubat M, Balija M, Jernej B. Serotonin transporter gene promoter (5-HTTLPR) and intron 2 (VNTR) polymorphisms in Croatian suicide victims. Biological Psychiatry. 2003;54:884–889
  9. Huang YY, Grailhe R, Arango V, Hen R, Mann JJ. Relationship of psychopathology to the human serotonin1B genotype and receptor binding kinetics in postmortem brain tissue. Neuropsychopharmacology. 1999;21:238–246
  10. Huang YY, Oquendo MA, Friedman JM, Greenhill LL, Brodsky B, Malone KM, et al. Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism. Neuropsychopharmacology. 2003;28:163–169
  11. Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. Journal of Neuroscience. 2003;23:8788–8799
  12. Li D, He L. Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior. Molecular Psychiatry. 2007;12:47–54
  13. McGuffin P, Katz R, Watkins S, Rutherford J. A hospital-based twin register of the heritability of DSM-IV unipolar depression. Archives of General Psychiatry. 1996;53:129–136
  14. Meltzer H. Serotonergic dysfunction in depression. British Journal of Psychiatry. 1989;8(Supplement):25–31
  15. Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwin GM, et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet. 1996;347:731–733
  16. Pooley EC, Houston K, Hawton K, Harrison PJ. Deliberate self-harm is associated with allelic variation in the tryptophan hydroxylase gene (TPH A779C), but not with polymorphisms in five other serotonergic genes. Psychological Medicine. 2003;33:775–783
  17. Rujescu D, Giegling I, Sato T, Moeller HJ. A polymorphism in the promoter of the serotonin transporter gene is not associated with suicidal behavior. Psychiatric Genetics. 2001;11:169–172
  18. Sawiniec J, Borkowski K, Ginalska G, Lewandowska-Stanek H. Association between 5-hydroxytryptamine 1A receptor gene polymorphism and suicidal behavior. Przeglad Lekarski. 2007;64:208–211
  19. Tao R, Wei J, Guo Y, Yu Y, Xu Q, Shi J, et al. The PLA2G4A gene and negative symptoms in a Chinese population. Schizophrenia Research. 2006;86:326–328
  20. Tsai SJ, Hong CJ, Yu YW, Chen TJ, Wang YC, Lin WK. Association study of serotonin 1B receptor (A-161T) genetic polymorphism and suicidal behaviors and response to fluoxetine in major depressive disorder. Neuropsychobiology. 2004;50:235–238
  21. Wittchen HU, Essau CA, von Zerssen D, Krieg JC, Zaudig M. Lifetime and six-month prevalence of mental disorders in the Munich Follow-Up Study. European Archives of Psychiatry and Clinical Neuroscience. 1992;241:247–258
  22. Zhang H, Ju G, Wei J, Hu Y, Liu L, Xu Q, et al. A combined effect of the KPNA3 and KPNB3 genes on susceptibility to schizophrenia. Neuroscience Letters. 2006;402:173–175

PII: S0165-1781(08)00443-5

doi: 10.1016/j.psychres.2008.12.006

Psychiatry Research
Volume 170, Issue 2 , Pages 204-207 , 30 December 2009

Article Tools